Invention Grant
- Patent Title: Pyridopyrimidine derivatives as protein kinase inhibitors
-
Application No.: US14420003Application Date: 2013-07-10
-
Publication No.: US09725462B2Publication Date: 2017-08-08
- Inventor: Lars Burgdorf , Daniel Kuhn , Tatjana Ross , Carl Deutsch
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp; Anthony Zelano
- Priority: EP12005716 20120807
- International Application: PCT/EP2013/002032 WO 20130710
- International Announcement: WO2014/023385 WO 20140213
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; C07D498/04 ; A61K31/538 ; A61K31/5383 ; A61P35/04 ; A61P29/00 ; A61P9/00 ; A61P25/28 ; A61P3/00 ; A61P31/00 ; A61P37/00
Abstract:
Compounds of the formula I in which R, R1 and R2 have the meanings indicated in claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and/or systemic lupus.
Public/Granted literature
- US20150218186A1 PYRIDOPYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS Public/Granted day:2015-08-06
Information query
